Keratoconjunctivitis Sicca
Showing NaN - NaN of 5
Sjogren's Syndrome, Keratoconjunctivitis Sicca Trial in Nashville (Levocarnitine, Placebo)
Recruiting
- Sjogren's Syndrome
- Keratoconjunctivitis Sicca
- Levocarnitine
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 31, 2022
Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,
Completed
- Dry Eye Syndrome
- Keratoconjunctivitis Sicca
- 0.05% Voclosporin Ophthalmic Solution (VOS)
- +3 more
-
Newport Beach, California
- +8 more
Dec 8, 2021
Keratoconjunctivitis Sicca, Dry Eye Trial in United States (tavilermide ophthalmic solution, Placebo)
Completed
- Keratoconjunctivitis Sicca
- Dry Eye
- tavilermide ophthalmic solution
- Placebo
-
Phoenix, Arizona
- +21 more
Oct 18, 2021
Dry Eye Syndromes, Keratoconjunctivitis Sicca Trial in United States (KPI-121 0.25% Ophthalmic Suspension, Vehicle of KPI-121
Completed
- Dry Eye Syndromes
- Keratoconjunctivitis Sicca
- KPI-121 0.25% Ophthalmic Suspension
- Vehicle of KPI-121 0.25% Ophthalmic Suspension
-
Birmingham, Alabama
- +61 more
Dec 10, 2020
Keratoconjunctivitis Sicca Trial in Louisville, Nashville (1% Tavilermide Ophthalmic Solution, Placebo Ophthalmic Solution)
Completed
- Keratoconjunctivitis Sicca
- 1% Tavilermide Ophthalmic Solution
- Placebo Ophthalmic Solution
-
Louisville, Kentucky
- +1 more
Aug 13, 2019